Dizlin Pharmaceuticals AB is a privately held Swedish research-based pharmaceutical development company with focus on diseases of the central nervous system in general and on developing improved treatment for advanced stages of Parkinson’s disease in particular. The company conducts research in collaboration with researchers at the University of Gothenburg and Linköping University in Sweden. The company has developed a new patented method for treatment of advanced stages of Parkinson's disease. Dizlin Pharmaceuticals has two products in late phase development stage. The first - Infudopa IntraV™ – is administered intravenously to minimize risks associated with surgery on patients with Parkinson's disease. The second – Infudopa SubC™ – is administered as a continuous subcutaneous infusion by means of a portable pump (similar to insulin infusion for diabetes).
View Top Employees from Dizlin Pharmaceuticals ABWebsite | http://www.dizlin.se |
Employees | 6 (1 on RocketReach) |
Founded | 2008 |
Address | 8a C/o Sahlgrenska Science Park Medicinaregatan, Goeteborg, Vaestra Goetaland 413 90, SE |
Phone | +46 76 879 23 25 |
Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Dizlin Pharmaceuticals AB employee's phone or email?
Johan Unger is the Board Member of Dizlin Pharmaceuticals AB.
1 people are employed at Dizlin Pharmaceuticals AB.
Dizlin Pharmaceuticals AB is based in Goeteborg, Vaestra Goetaland.
The NAICS codes for Dizlin Pharmaceuticals AB are [325, 32541, 3254, 32].
The SIC codes for Dizlin Pharmaceuticals AB are [2834, 28, 283].